High grade osteosarcoma of the extremities with lung metastases at presentation: Treatment with neoadjuvant chemotherapy and simultaneous resection of primary and metastatic lesions

Bacci, Gaetano, Rocca, Michele, Salone, MariaCristina, Balladelli, Alba, Ferrari, Stefano, Palmerini, Emanuela, Forni, Cristiana, Briccoli, Antonio·2008·Journal of Surgical Oncology

Cited by (206)

Items 201–206 of 206

  1. Additional file 3 of RhoA enhances osteosarcoma resistance to MPPa-PDT via the Hippo/YAP signaling pathway
    Zhan, Fangbiao, He, Tao, Chen, Zhiyu, Zuo, Qiang, Wang, Yang, Qiaochu Li, Shenxi Zhong, 欧云生 · 2021 · Figshare
  2. Amino acid metabolism-related genes signature correlates with immune infiltration and predicts clinic prognosis in osteosarcoma
    Deshuang Xi, Yilin Teng, Shaobo Wang, M Zhang, Gang Liu, Bo Han, Y T Zhang, Xiao Tian, Chunxin Cheng, Shouguo Wang et al. · 2026 · BMC Cancer
  3. A diagnostic nomogram for synchronous lung metastasis at initial diagnosis in osteosarcoma: A retrospective SEER database study
    Sisi Ge, Yali Yu, Lin Hu, Yanli Niu · 2026 · Journal of orthopaedic surgery
  4. A gallium(III)-polypyridyl complex bearing chrysin with anti-osteosarcoma stem cell activity
    Xiao Shan Feng, Maximus Gordon, Hao Ren, Fabrizio Ortu, Kogularamanan Suntharalingam · 2026 · Canadian Journal of Chemistry
  5. Prognostic factors in pediatric osteosarcoma presenting with pulmonary metastasis: experience of the Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology
    Elena I. Konopleva, Н. Г. Ускова, Талыпов Сергей Римович, Sergey V Orlov, Олег Иванович Быданов, N. A. Bolshakov, Дмитрий Гурамович Ахаладзе, Galina A. Novichkova, Николай Сергеевич Грачев, Alexander I. Karachunskiy · 2026 · Pediatric Hematology/Oncology and Immunopathology
  6. TSSC3 as a potential biomarker in osteosarcoma: implications for angiogenesis
    Hanzhen Feng, Wenmang Xu, Qiang Feng, Xiaolong Wei, Meijin Huang, Ziran Gao · 2026 · Folia Histochemica et Cytobiologica